Exploring the Role of Hsp60 in Alzheimer’s Disease and Type 2 Diabetes: Suggestion for Common Drug Targeting

Heat shock protein 60 (Hsp60) is a member of the chaperonin family of heat shock proteins (HSPs), primarily found in the mitochondrial matrix. As a molecular chaperone, Hsp60 plays an essential role in mediating protein folding and assembly, and together with the co-chaperon Hsp10, it is thought to...

Full description

Bibliographic Details
Main Authors: Stefania Zimbone, Maria Carmela Di Rosa, Santina Chiechio, Maria Laura Giuffrida
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/15/12456
_version_ 1797586600980381696
author Stefania Zimbone
Maria Carmela Di Rosa
Santina Chiechio
Maria Laura Giuffrida
author_facet Stefania Zimbone
Maria Carmela Di Rosa
Santina Chiechio
Maria Laura Giuffrida
author_sort Stefania Zimbone
collection DOAJ
description Heat shock protein 60 (Hsp60) is a member of the chaperonin family of heat shock proteins (HSPs), primarily found in the mitochondrial matrix. As a molecular chaperone, Hsp60 plays an essential role in mediating protein folding and assembly, and together with the co-chaperon Hsp10, it is thought to maintain protein homeostasis. Recently, it has been found to localize in non-canonical, extra-mitochondrial sites such as cell membranes or extracellular fluids, particularly in pathological conditions. Starting from its biological function, this review aims to provide a comprehensive understanding of the potential involvement of Hsp60 in Alzheimer’s disease (AD) and Type II Diabetes Mellitus (T2DM), which are known to share impaired key pathways and molecular dysfunctions. Fragmentary data reported in the literature reveal interesting links between the altered expression level or localization of this chaperonin and several disease conditions. The present work offers an overview of the past and more recent knowledge about Hsp60 and its role in the most important cellular processes to shed light on neuronal Hsp60 as a potential common target for both pathologies. The absence of any effective cure for AD patients makes the identification of a new molecular target a promising path by which to move forward in the development of new drugs and/or repositioning of therapies already used for T2DM.
first_indexed 2024-03-11T00:24:22Z
format Article
id doaj.art-5de32e2ac82e45ae949e9706c70b0d5d
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T00:24:22Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-5de32e2ac82e45ae949e9706c70b0d5d2023-11-18T23:05:18ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-08-0124151245610.3390/ijms241512456Exploring the Role of Hsp60 in Alzheimer’s Disease and Type 2 Diabetes: Suggestion for Common Drug TargetingStefania Zimbone0Maria Carmela Di Rosa1Santina Chiechio2Maria Laura Giuffrida3Institute of Crystallography, National Research Council (CNR-IC), 95126 Catania, ItalyInstitute of Crystallography, National Research Council (CNR-IC), 95126 Catania, ItalyDepartment of Drug and Health Sciences, University of Catania, 95125 Catania, ItalyInstitute of Crystallography, National Research Council (CNR-IC), 95126 Catania, ItalyHeat shock protein 60 (Hsp60) is a member of the chaperonin family of heat shock proteins (HSPs), primarily found in the mitochondrial matrix. As a molecular chaperone, Hsp60 plays an essential role in mediating protein folding and assembly, and together with the co-chaperon Hsp10, it is thought to maintain protein homeostasis. Recently, it has been found to localize in non-canonical, extra-mitochondrial sites such as cell membranes or extracellular fluids, particularly in pathological conditions. Starting from its biological function, this review aims to provide a comprehensive understanding of the potential involvement of Hsp60 in Alzheimer’s disease (AD) and Type II Diabetes Mellitus (T2DM), which are known to share impaired key pathways and molecular dysfunctions. Fragmentary data reported in the literature reveal interesting links between the altered expression level or localization of this chaperonin and several disease conditions. The present work offers an overview of the past and more recent knowledge about Hsp60 and its role in the most important cellular processes to shed light on neuronal Hsp60 as a potential common target for both pathologies. The absence of any effective cure for AD patients makes the identification of a new molecular target a promising path by which to move forward in the development of new drugs and/or repositioning of therapies already used for T2DM.https://www.mdpi.com/1422-0067/24/15/12456Hsp60Alzheimer’s diseasetype 2 diabetes mellitusIGF-IR
spellingShingle Stefania Zimbone
Maria Carmela Di Rosa
Santina Chiechio
Maria Laura Giuffrida
Exploring the Role of Hsp60 in Alzheimer’s Disease and Type 2 Diabetes: Suggestion for Common Drug Targeting
International Journal of Molecular Sciences
Hsp60
Alzheimer’s disease
type 2 diabetes mellitus
IGF-IR
title Exploring the Role of Hsp60 in Alzheimer’s Disease and Type 2 Diabetes: Suggestion for Common Drug Targeting
title_full Exploring the Role of Hsp60 in Alzheimer’s Disease and Type 2 Diabetes: Suggestion for Common Drug Targeting
title_fullStr Exploring the Role of Hsp60 in Alzheimer’s Disease and Type 2 Diabetes: Suggestion for Common Drug Targeting
title_full_unstemmed Exploring the Role of Hsp60 in Alzheimer’s Disease and Type 2 Diabetes: Suggestion for Common Drug Targeting
title_short Exploring the Role of Hsp60 in Alzheimer’s Disease and Type 2 Diabetes: Suggestion for Common Drug Targeting
title_sort exploring the role of hsp60 in alzheimer s disease and type 2 diabetes suggestion for common drug targeting
topic Hsp60
Alzheimer’s disease
type 2 diabetes mellitus
IGF-IR
url https://www.mdpi.com/1422-0067/24/15/12456
work_keys_str_mv AT stefaniazimbone exploringtheroleofhsp60inalzheimersdiseaseandtype2diabetessuggestionforcommondrugtargeting
AT mariacarmeladirosa exploringtheroleofhsp60inalzheimersdiseaseandtype2diabetessuggestionforcommondrugtargeting
AT santinachiechio exploringtheroleofhsp60inalzheimersdiseaseandtype2diabetessuggestionforcommondrugtargeting
AT marialauragiuffrida exploringtheroleofhsp60inalzheimersdiseaseandtype2diabetessuggestionforcommondrugtargeting